Abbott Laboratories (ABT) Faces Class-Action Lawsuit Over PediaSure

AI Summary

A federal judge ruled that Abbott Laboratories (ABT) must face a class-action lawsuit regarding allegations it misled consumers about PediaSure Grow & Gain drinks being 'clinically proven' for children's growth. The lawsuit claims the marketing could mislead consumers into interpreting growth as height gain, while using labels suggesting weight gain. Plaintiff Joanne Noriega alleges her grandson remained short after a year of daily use. Abbott maintains its labeling is appropriate and evidence-based, stating PediaSure supports children's growth and development.